Exhibit 10.42

AMENDMENT TO CONSULTING AGREEMENT

This Amendment to Consulting Agreement (Amendment) is
made and entered into by and between SCOLR Pharma, Inc., a Delaware corporation, formerly known as Nutraceutix, Inc., and Dr. Reza Fassihi (Dr. Fassihi). Effective as of December 31, 2006, the Consulting Agreement dated as of
December 22, 2000 (the Consulting Agreement), and the Additional Services Agreement (the additional Services Agreement) effective as of August 7, 2002, between SCOLR and Dr. Fassihi, are hereby amended as
follows:



| | 1. | Paragraph 1 of the Consulting Agreement is hereby amended to provide that the Term shall continue until terminated in accordance with paragraph 14 of the Consulting Agreement.
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | The second sentence of Paragraph 2 of the Consulting Agreement shall be replaced with the following: During the Term, Dr. Fassihi shall provide such additional Services
as may be mutually agreed upon by the parties from time to time.
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 3. | Except as specifically set forth in this Agreement, the Consulting Agreement and the Additional Services Agreement shall remain in full force and effect.
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------

IN WITNESS WHEREOF, the parties have executed this Agreement as of this 18th day of January 2007:



|                           |  |                                                 |  |                            |  |          |  |                                               
|-------------------------- |  | ----------------------------------------------- |  | -------------------------- |  | -------- |  | ----------------------------------------------
|SCOLR Pharma, Inc.         |  |                                                 |  | Dr. Fassihi               
|                           |  |                                                 |  |                           
|By:                        |  | /s/ Daniel O. Wilds                             |  |                            |  | By:      |  | /s/ Reza Fassihi                              
|                           |  | Daniel O. Wilds President & CEO                 |  |                            |  |          |  | Dr. Reza Fassihi                              
|                           |  |                                                 |  |                           
|Address:                   |  | 3625 132ndAve.
SE, Suite 400 Bellevue, WA 98006 |  |                            |  | Address: |  | 352 Dreshertown Road Fort Washington, PA
19034
|                           |  |                                                
|Date Signed: Jan. 18, 2007 |  |                                                 |  | Date Signed: Jan. 11, 2007